DMS administration significantly increased the number of newborn neurons and immature neurons identified as BrdU+/NeuN+ cells as well as the number of DCX+ cells in the DG of 5XFAD mice, suggesting that deficits in proliferation and differentiation of neural progenitor cells in AD transgenic mice could be rescued by DMS. The gene discussed is RBFOX3; the disease is Alzheimer disease.